Matt Zuga's Net Worth
$16.9 Million
Who is Matt Zuga?
Matt Zuga has an estimated net worth of $16.9 Million. This is based on reported shares across multiple companies, which include HighCape Capital Acquisition Corp., Acumen Pharmaceuticals, Inc., ELUTIA INC., and TELA Bio, Inc..
SEC CIK
Matt Zuga's CIK is 0001790214
Past Insider Trading and Trends
2019 was Matt Zuga's most active year for acquiring shares with 8 total transactions. Matt Zuga's most active month to acquire stocks was the month of October. 2019 was Matt Zuga's most active year for disposing of shares, totalling 6 transactions. Matt Zuga's most active month to dispose stocks was the month of October. 2020 saw Matt Zuga paying a total of $7,541,653.57 for 4,511,282 shares, this is the most they've acquired in one year. In 2020 Matt Zuga cashed out on 31,144,083 shares for a total of $13,339.32, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
HighCape Capital Acquisition Corp. (QSI) Snapshot price: $1.6
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Acumen Pharmaceuticals, Inc. (ABOS) Snapshot price: $3.19
CFO & Chief Business Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.97% | -4.24K |
$3.71 | -$15,716.61 | 211.44K |
Scheduled
|
Jan 18
| ||
Form 4
| +96.64% | 106K |
—
|
—
| 215.69K |
Jan 2
| |||
Form 4
| +43.97% | 33.5K |
—
|
—
| 109.69K |
Jan 17
| |||
Form 4
| +190.93% | 50K |
$1.19 | $59,500.00 | 76.19K |
Dec 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 19
| |||
Form 4
|
∞
| 26.19K |
—
|
—
| 26.19K |
Jul 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ELUTIA INC. (ELUT) Snapshot price: $3.81
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -17.03% | -1.44M |
—
|
—
| 7M |
Dec 28
| |||
Form 4
| +50.68% | 2.84M |
—
|
—
| 8.43M |
Sep 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 22
| |||
Form 4
| +15.12% | 735K |
$4.75 | $3,491,250.00 | 5.6M |
Dec 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
| +9.09% | 412.74K |
$4.24 | $1,749,996.40 | 4.95M |
Dec 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
∞
| 4.51M |
$11.12 | $7,528,314.25 | 4.51M |
Oct 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TELA Bio, Inc. (TELA) Snapshot price: $6.83
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +174.59% | 327.12K |
$13.00 |
—
| 514.48K |
Nov 8 - Nov 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||